2.
Dosage and administration methods of indocyanine green
| Purpose | Injection time | Administration method | Injection dosage |
| IV: Injection through peripheral vein; NAH: Nonanatomical hepatectomy; AH: Anatomical hepatectomy; PV: Injection through portal vein of the targeted hepatic segment; IA: Injection through femoral artery puncture surpassing selective hepatic segment artery. | |||
| Identification and location of tumors | Based on ICG R15 | IV | 0.25-0.5 mg/kg |
| Definition of tumor boundaries | Based on ICG R15 | IV | 0.25-0.5 mg/kg |
| Detection of residual liver | Based on ICG R15 | IV | 0.25-0.5 mg/kg |
| Hepatic segmentation (Negative Display Method) | Intraoperative | IV | 1 mL (2.5 mg/mL) |
| Hepatic segmentation (Positive Display Method) | Intraoperative | PV | 0.1 mL (2.5 mg/mL) mixed with 5.0 mL indigo carmine |
| Hepatic segmentation (Experimental phase) | Intraoperative | IA | 1 mL (1 mg/mL) |
| Delineation of hepatectomy line (NAH) | Preoperative | IV | 0.25-0.5 mg/kg |
| Delineation of hepatectomy line (AH) | Intraoperative | IV/PV | Refer to hepatic segmentation dose |
| Detection of Biliary Leakage in Liver Section | Intraoperative | Transcystic duct | 5-10 mL (2.5 mg/mL) |
| Living donor liver transplantation (Biliary reconstruction) | Intraoperative | Transcystic duct | 2 mL (2.5 mg/mL) |
| Living donor liver transplantation (Revascularization) | Intraoperative | IV | 1.5 mL (2.5 mg/mL) |